Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa

Background: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic a...

Full description

Bibliographic Details
Main Authors: Teboho Amelia Tiiti, Tebogo Loraine Mashishi, Varsetile Varster Nkwinika, Kgotlaethata Aaron Molefi, Ina Benoy, Johannes Bogers, Selokela Gloria Selabe, Ramokone Lisbeth Lebelo
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/21/4817
_version_ 1797512352301580288
author Teboho Amelia Tiiti
Tebogo Loraine Mashishi
Varsetile Varster Nkwinika
Kgotlaethata Aaron Molefi
Ina Benoy
Johannes Bogers
Selokela Gloria Selabe
Ramokone Lisbeth Lebelo
author_facet Teboho Amelia Tiiti
Tebogo Loraine Mashishi
Varsetile Varster Nkwinika
Kgotlaethata Aaron Molefi
Ina Benoy
Johannes Bogers
Selokela Gloria Selabe
Ramokone Lisbeth Lebelo
author_sort Teboho Amelia Tiiti
collection DOAJ
description Background: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic acid (mRNA). The study aimed to evaluate the performance of the SelfCerv applicator tampon for the detection of hr-HPV for cervical cancer screening, and further to investigate women’s experiences and preferences regarding self-sampling. Methods: Vaginal samples were collected from 527 gynecology clinic attendees aged ≥18 years at a tertiary hospital in Gauteng Province, South Africa. Self-samples were collected using the SelfCerv kit, followed by endocervical samples collected by a healthcare professional using Cervex-Brush<sup>®</sup> Combi. Participants completed a self-administered questionnaire on self-sampling experiences and preferences. Both samples were tested for 14 high-risk (hr) HPV types and E6/E7 mRNA using the Abbott RealTime HR-HPV and Aptima HR-HPV mRNA assays, respectively. Results: The overall agreement for hr-HPV typing between 527 paired samples was good (87.1%; κ =0.74) with high sensitivity (86.2%) and specificity (88.0%). HPV-16 (96.4%; κ = 0.83) had higher agreement rate than HPV-18 (96.8%; κ = 0.72) and the other 12 hr-HPVs (86.5%; κ = 0.72). Two hundred and eighty-five (285) sample pairs tested for E6/E7 mRNA showed fair agreement (70.2%; κ= 0.34). Furthermore, self-sampling was reported as comfortable (90.5%) and painless (86.7%), with 88.4% of women preferring self-collection. Conclusions: Self-collected samples had good agreement with the healthcare professional-collected samples for the detection of hr-HPV DNA and the procedure was highly preferred by women. Self-sampling using SelfCerv can be used as an alternative to healthcare professional sampling in clinic-based routine cervical cancer screening.
first_indexed 2024-03-10T05:59:39Z
format Article
id doaj.art-4ebf7f6868f04990b141a183e050a92a
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T05:59:39Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-4ebf7f6868f04990b141a183e050a92a2023-11-22T21:03:00ZengMDPI AGJournal of Clinical Medicine2077-03832021-10-011021481710.3390/jcm10214817Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South AfricaTeboho Amelia Tiiti0Tebogo Loraine Mashishi1Varsetile Varster Nkwinika2Kgotlaethata Aaron Molefi3Ina Benoy4Johannes Bogers5Selokela Gloria Selabe6Ramokone Lisbeth Lebelo7Department of Virological Pathology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaDepartment of Virological Pathology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaDepartment of Virological Pathology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaDepartment of Obstetrics and Gynaecology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaLaboratory of Cell Biology and Histology, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerpen, BelgiumLaboratory of Cell Biology and Histology, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerpen, BelgiumDepartment of Virological Pathology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaDepartment of Virological Pathology, Sefako Makgatho Health Sciences University, Pretoria 0204, South AfricaBackground: The SelfCerv Self-Collection Cervical Health Screening Kit (Ilex Medical Ltd., Johannesburg, South Africa) is an applicator tampon designed for self-collection of vaginal samples for the detection of human papillomavirus (HPV) deoxyribonucleic acid (DNA) and E6/E7 messenger ribonucleic acid (mRNA). The study aimed to evaluate the performance of the SelfCerv applicator tampon for the detection of hr-HPV for cervical cancer screening, and further to investigate women’s experiences and preferences regarding self-sampling. Methods: Vaginal samples were collected from 527 gynecology clinic attendees aged ≥18 years at a tertiary hospital in Gauteng Province, South Africa. Self-samples were collected using the SelfCerv kit, followed by endocervical samples collected by a healthcare professional using Cervex-Brush<sup>®</sup> Combi. Participants completed a self-administered questionnaire on self-sampling experiences and preferences. Both samples were tested for 14 high-risk (hr) HPV types and E6/E7 mRNA using the Abbott RealTime HR-HPV and Aptima HR-HPV mRNA assays, respectively. Results: The overall agreement for hr-HPV typing between 527 paired samples was good (87.1%; κ =0.74) with high sensitivity (86.2%) and specificity (88.0%). HPV-16 (96.4%; κ = 0.83) had higher agreement rate than HPV-18 (96.8%; κ = 0.72) and the other 12 hr-HPVs (86.5%; κ = 0.72). Two hundred and eighty-five (285) sample pairs tested for E6/E7 mRNA showed fair agreement (70.2%; κ= 0.34). Furthermore, self-sampling was reported as comfortable (90.5%) and painless (86.7%), with 88.4% of women preferring self-collection. Conclusions: Self-collected samples had good agreement with the healthcare professional-collected samples for the detection of hr-HPV DNA and the procedure was highly preferred by women. Self-sampling using SelfCerv can be used as an alternative to healthcare professional sampling in clinic-based routine cervical cancer screening.https://www.mdpi.com/2077-0383/10/21/4817South AfricaSelfCervHPVcervical cancerself-samplingE6/E7 mRNA
spellingShingle Teboho Amelia Tiiti
Tebogo Loraine Mashishi
Varsetile Varster Nkwinika
Kgotlaethata Aaron Molefi
Ina Benoy
Johannes Bogers
Selokela Gloria Selabe
Ramokone Lisbeth Lebelo
Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
Journal of Clinical Medicine
South Africa
SelfCerv
HPV
cervical cancer
self-sampling
E6/E7 mRNA
title Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_full Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_fullStr Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_full_unstemmed Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_short Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
title_sort evaluation of ilex selfcerv for detection of high risk human papillomavirus infection in gynecology clinic attendees at a tertiary hospital in south africa
topic South Africa
SelfCerv
HPV
cervical cancer
self-sampling
E6/E7 mRNA
url https://www.mdpi.com/2077-0383/10/21/4817
work_keys_str_mv AT tebohoameliatiiti evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT tebogolorainemashishi evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT varsetilevarsternkwinika evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT kgotlaethataaaronmolefi evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT inabenoy evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT johannesbogers evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT selokelagloriaselabe evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica
AT ramokonelisbethlebelo evaluationofilexselfcervfordetectionofhighriskhumanpapillomavirusinfectioningynecologyclinicattendeesatatertiaryhospitalinsouthafrica